Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.30B | 14.11B | 13.95B | 12.69B | 13.02B | 12.64B |
Gross Profit | 13.93B | 0.00 | 13.95B | 12.69B | 13.02B | 12.64B |
EBITDA | 1.55B | 1.98B | 2.43B | 2.59B | 2.40B | 2.29B |
Net Income | 1.47B | 1.07B | 1.38B | 1.53B | 1.34B | 1.15B |
Balance Sheet | ||||||
Total Assets | 1.03T | 1.01T | 1.01T | 968.13B | 1.03T | 1.02T |
Cash, Cash Equivalents and Short-Term Investments | 95.37B | 0.00 | 84.02B | 43.69B | 167.68B | 157.50B |
Total Debt | 34.04B | 1.11B | 1.16B | 2.91B | 79.36B | 71.98B |
Total Liabilities | 996.27B | 974.24B | 973.26B | 929.39B | 987.05B | 981.42B |
Stockholders Equity | 37.51B | 35.38B | 39.44B | 38.74B | 39.92B | 40.10B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 25.75B | 24.84B | -111.45B | 10.89B | 127.26B |
Operating Cash Flow | 0.00 | 26.16B | 25.61B | -110.90B | 11.06B | 127.67B |
Investing Cash Flow | 0.00 | -37.86B | -2.09B | -11.28B | -916.00M | -3.09B |
Financing Cash Flow | 0.00 | -8.37B | -477.00M | -475.00M | -474.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥28.01B | 6.20 | 3.95% | 2.37% | -29.71% | ||
72 Outperform | ¥25.84B | 6.56 | 3.85% | -4.52% | 85.81% | ||
69 Neutral | ¥10.69B | 10.01 | 4.44% | -2.78% | 13.42% | ||
68 Neutral | ¥724.27B | 10.74 | 7.55% | 3.29% | 7.97% | 15.90% | |
62 Neutral | ¥9.05B | 6.80 | 4.48% | 2.13% | 10.94% | ||
61 Neutral | ¥168.61B | 10.77 | 3.66% | 1.24% | 38.84% | ||
50 Neutral | ¥7.85B | ― | 2.22% | 1.71% | -164.25% |